000
| 02118cam 2200397zi 4500 |
---|
001 | 9.944698 |
---|
003 | CaOODSP |
---|
005 | 20241031111735 |
---|
006 | m o d f |
---|
007 | cr mn||||||||| |
---|
008 | 241030t20242024onc ob f000 0 eng d |
---|
040 | |aCaOODSP|beng|erda|cCaOODSP |
---|
043 | |an-cn--- |
---|
086 | 1 |aH113-28/2024-8E-PDF |
---|
245 | 00|aNatamycin and its associated end-use products : |bfinal decision. |
---|
264 | 1|aOttawa, Ontario : |bPest Management Regulatory Agency, Health Canada, |c2024. |
---|
264 | 4|c©2024 |
---|
300 | |a1 online resource (10 pages). |
---|
336 | |atext|btxt|2rdacontent |
---|
337 | |acomputer|bc|2rdamedia |
---|
338 | |aonline resource|bcr|2rdacarrier |
---|
490 | 1 |aRe-evaluation decision, |x1925-1025 ; |vRVD2024-08 |
---|
500 | |aCover title. |
---|
500 | |aIssued also in French under title: Natamycine et préparations commerciales connexes : décision finale. |
---|
500 | |a"24 October 2024." |
---|
504 | |aIncludes bibliographical references. |
---|
520 | |a"This document presents the final re-evaluation decision for the re-evaluation of natamycin, including the response to comments received, and the required label updates. All products containing natamycin regulated under the Pest Control Products Act in Canada are subject to this re-evaluation decision"--Page 1. |
---|
650 | 0|aAntifungal agents|xCertification|zCanada. |
---|
650 | 0|aAntifungal agents|xRisk assessment|zCanada. |
---|
650 | 0|aAntifungal agents|xRisk mitigation|zCanada. |
---|
710 | 1 |aCanada. |bPest Management Regulatory Agency, |eissuing body. |
---|
775 | 08|tNatamycine et préparations commerciales connexes : |w(CaOODSP)9.944719 |
---|
830 | #0|aRe-evaluation decision (Canada. Pest Management Regulatory Agency)|vRVD2024-08.|w(CaOODSP)9.505209 |
---|
856 | 40|qPDF|s254 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/h113-28/H113-28-2024-8-eng.pdf |
---|
856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/consumer-product-safety/reports-publications/pesticides-pest-management/decisions-updates/reevaluation-decision/2024/natamycin.html |
---|